MUSC's Nuclear Medicine Department was granted accreditation by the
Intersocietal Commission for the Accreditation of Nuclear Medicine
Laboratories (ICANL). The laboratory is one of a growing number of
nuclear medicine laboratories in the United States, Canada and Puerto
Rico to be recognized for its commitment to high quality patient care
and its provision of quality diagnostic testing.
More than 10 million nuclear medicine imaging and therapeutic
procedures are performed each year in the United States. The imaging
procedure is effectively used in a broad range of medical specialties,
from pediatrics to cardiology to psychiatry, to safely diagnose and
treat disease. In children, nuclear medicine tests are used to evaluate
bone pain, injuries infection or kidney and bladder function. In
adults, the test is used to analyze the heart, bone scans for
orthopaedic injuries, lung scans for blood clots, and liver and gall
bladder procedures to diagnose abnormal function or blockage.
ICANL was established with support from the American Society of Nuclear
Cardiology, the Society of Nuclear Medicine and the Society of Nuclear
Medicine Technologist Section, the American College of Cardiology, the
American College of Nuclear Physicians and the Academy of Molecular
Imaging. ICANL provides a peer review mechanism to encourage and
recognize the provision of quality nuclear medicine diagnostic
evaluations by a process of voluntary accreditation.
Participation in the accreditation process is voluntary. Accreditation
status signifies that MUSC has been reviewed by an independent agency
that recognizes the laboratory's commitment to quality testing.
Friday, Nov. 20, 2009